Login to Your Account



Corruption scandal is game changer in China

By Shannon Ellis
Staff Writer

Wednesday, February 12, 2014

SHANGHAI – The anti-corruption storm last summer that engulfed much of the biopharmaceutical industry here – with Glaxosmithkline plc at the center – was a game changer for China, primarily due to the amount of information released about the case from the very the beginning, contrary to what one would expect from the usually opaque Chinese government.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription